What is Jefferies's price target for PNT?

Jefferies's latest stated price target for POINT Biopharma Global Inc. (PNT) is $14, from its action on Jul 20, 2023.

What is Jefferies's rating on PNT?

Jefferies rates PNT Buy, a bullish rating, as of Jul 20, 2023.

When did Jefferies last change its view on PNT?

On Jul 20, 2023, Jefferies resumes coverage at Buy, price target $12 to $14.

Jefferies PNT price target and rating history

POINT Biopharma Global Inc. (PNT) · Health Care

Jefferies rates POINT Biopharma Global Inc. (PNT) Buy with a $14 price target, as of its latest action on Jul 20, 2023. It has published 3 rating actions on PNT since July 2021, including 1 upgrade and 0 downgrades.

Current rating: Buy
Price target: $14
Median target, all firms: Too few
Actions on PNT: 3

Jefferies price target on PNT

Jefferies price target on PNT, each point a stated target, July 2021 to July 2023.

Every Jefferies rating on PNT

Jul 20, 2023
ResumeJefferies resumes coverage at Buy, price target $12 to $14
May 26, 2022
UpgradeJefferies upgrades to Buy from Hold, price target $7 to $20
Jul 27, 2021
InitiateJefferies starts coverage at Hold, price target $8

Questions about Jefferies and PNT

What is Jefferies's price target for PNT?: Jefferies's latest stated price target for POINT Biopharma Global Inc. (PNT) is $14, from its action on Jul 20, 2023.
What is Jefferies's rating on PNT?: Jefferies rates PNT Buy, a bullish rating, as of Jul 20, 2023.
When did Jefferies last change its view on PNT?: On Jul 20, 2023, Jefferies resumes coverage at Buy, price target $12 to $14.

All Jefferies ratings PNT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.